← Evidence map

ReviewAntiviral chemistry & chemotherapy

Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration.

Erik De ClercqPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

108 papers cite itlatest 60 shown

2021
2022
2023
2024
2025
2026
pooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 30776910